Shanghai - Delayed Quote CNY
Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
8.05
-0.18
(-2.19%)
At close: April 28 at 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,369,601.36
2,195,986.15
2,131,239.99
1,999,916.89
1,367,087.24
Cost of Revenue
1,845,966.44
1,662,658.92
1,618,787.93
1,251,941.29
765,728.49
Gross Profit
523,634.92
533,327.24
512,452.06
747,975.60
601,358.75
Operating Expense
365,522.64
356,488.36
340,556.22
267,843.95
236,069.34
Operating Income
158,112.28
176,838.88
171,895.84
480,131.65
365,289.41
Net Non Operating Interest Income Expense
-88,578.09
-101,105.79
-86,806.20
-70,350.11
-89,845.80
Pretax Income
18,834.16
45,352.18
-65,404.55
395,392.01
303,698.51
Tax Provision
4,532.05
798.82
6,525.69
65,623.63
50,101.22
Net Income Common Stockholders
13,890.41
44,232.09
-75,850
323,754.75
238,729.34
Basic EPS
0.04
0.13
-0.22
0.94
0.71
Diluted EPS
0.04
0.13
-0.22
0.94
0.71
Basic Average Shares
408,766.69
340,246.84
344,772.74
344,419.95
334,221.08
Diluted Average Shares
408,766.69
340,246.84
344,772.74
340,794.48
334,221.08
Total Operating Income as Reported
22,194.63
49,191.36
-55,789.65
399,765.46
293,935.25
Total Expenses
2,211,489.08
2,019,147.28
1,959,344.15
1,519,785.24
1,001,797.83
Net Income from Continuing & Discontinued Operation
13,890.41
44,232.09
-75,850
323,754.75
238,729.34
Normalized Income
37,111.92
60,960.74
18,074.72
336,977.88
243,172.83
Interest Income
9,317.32
7,547.52
9,697.16
5,702.36
3,916.62
Interest Expense
92,382.48
102,604.14
92,600.22
73,822.59
92,040.47
Net Interest Income
-88,578.09
-101,105.79
-86,806.20
-70,350.11
-89,845.80
EBIT
111,216.63
147,956.32
27,195.67
469,214.59
395,738.99
EBITDA
111,216.63
327,509.92
187,637.75
624,180
521,967.93
Reconciled Cost of Revenue
1,845,966.44
1,662,658.92
1,618,787.93
1,251,941.29
765,728.49
Reconciled Depreciation
--
179,553.60
160,442.07
154,965.41
126,228.94
Net Income from Continuing Operation Net Minority Interest
13,890.41
44,232.09
-75,850
323,754.75
238,729.34
Total Unusual Items Excluding Goodwill
-30,579.95
-17,028.59
-125,232.97
-15,854.51
-5,321.36
Total Unusual Items
-30,579.95
-17,028.59
-125,232.97
-15,854.51
-5,321.36
Normalized EBITDA
141,796.58
344,538.51
312,870.71
640,034.51
527,289.28
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-7,358.44
-299.94
-31,308.24
-2,631.39
-877.87
12/31/2020 - 3/9/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade